32 related articles for article (PubMed ID: 21640077)
1. Cell type-specific differences in redox regulation and proliferation after low UVA doses.
Ciesielska S; Bil P; Gajda K; Poterala-Hejmo A; Hudy D; Rzeszowska-Wolny J
PLoS One; 2019; 14(1):e0205215. PubMed ID: 30682016
[TBL] [Abstract][Full Text] [Related]
2. Keratinocyte Motility Is Affected by UVA Radiation-A Comparison between Normal and Dysplastic Cells.
Niculiţe CM; Nechifor MT; Urs AO; Olariu L; Ceafalan LC; Leabu M
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29880745
[TBL] [Abstract][Full Text] [Related]
3. Prolonged overexpression of Wnt10b induces epidermal keratinocyte transformation through activating EGF pathway.
Lei M; Lai X; Bai X; Qiu W; Yang T; Liao X; Chuong CM; Yang L; Lian X; Zhong JL
Histochem Cell Biol; 2015 Sep; 144(3):209-21. PubMed ID: 25995040
[TBL] [Abstract][Full Text] [Related]
4. PIN1 inhibition suppresses osteoclast differentiation and inflammatory responses.
Cho YA; Jue SS; Bae WJ; Heo SH; Shin SI; Kwon IK; Lee SC; Kim EC
J Dent Res; 2015 Feb; 94(2):371-80. PubMed ID: 25512367
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the microRNA 200b (miRNA-200b) by transcriptional regulators PEA3 and ELK-1 protein affects expression of Pin1 protein to control anoikis.
Zhang X; Zhang B; Gao J; Wang X; Liu Z
J Biol Chem; 2013 Nov; 288(45):32742-32752. PubMed ID: 24072701
[TBL] [Abstract][Full Text] [Related]
6. Essential role of Pin1 via STAT3 signalling and mitochondria-dependent pathways in restenosis in type 2 diabetes.
Lv L; Zhang J; Zhang L; Xue G; Wang P; Meng Q; Liang W
J Cell Mol Med; 2013 Aug; 17(8):989-1005. PubMed ID: 23750710
[TBL] [Abstract][Full Text] [Related]
7. β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.
Damsky WE; Curley DP; Santhanakrishnan M; Rosenbaum LE; Platt JT; Gould Rothberg BE; Taketo MM; Dankort D; Rimm DL; McMahon M; Bosenberg M
Cancer Cell; 2011 Dec; 20(6):741-54. PubMed ID: 22172720
[TBL] [Abstract][Full Text] [Related]
8. Induction of ErbB2 by ultraviolet A irradiation: potential role in malignant transformation of keratinocytes.
Han CY; Lim SC; Choi HS; Kang KW
Cancer Sci; 2008 Mar; 99(3):502-9. PubMed ID: 18177484
[TBL] [Abstract][Full Text] [Related]
9. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
Marsolier J; Weitzman JB
Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
[TBL] [Abstract][Full Text] [Related]
10. Pin1 as an anticancer drug target.
Xu GG; Etzkorn FA
Drug News Perspect; 2009 Sep; 22(7):399-407. PubMed ID: 19890497
[TBL] [Abstract][Full Text] [Related]
11. Role of Pin1 in UVA-induced cell proliferation and malignant transformation in epidermal cells.
Han CY; Hien TT; Lim SC; Kang KW
Biochem Biophys Res Commun; 2011 Jun; 410(1):68-74. PubMed ID: 21640077
[TBL] [Abstract][Full Text] [Related]
12. Pin1 is required for ultraviolet A-stimulated cyclooxygenase-2 induction in mouse epidermal cells.
Quyen BT; Choi HK; Kang KW
Cancer Lett; 2013 Jul; 335(1):31-40. PubMed ID: 23380442
[TBL] [Abstract][Full Text] [Related]
13. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
[TBL] [Abstract][Full Text] [Related]
14. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
[TBL] [Abstract][Full Text] [Related]
15. 5'-Nitro-indirubinoxime inhibits epidermal growth factor- and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1.
Khanal P; Choi HK; Namgoong GM; Ahn SG; Yoon JH; Sohn H; Choi HS
Mol Carcinog; 2011 Dec; 50(12):961-71. PubMed ID: 21400615
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
